Upcoming Events
Oct 10, 2022

London, England

Nov 1 to Nov 3, 2022
CPHI 2022

Frankfurt, Germany 

Dec 10 to Dec 13, 2022
ASH 2022

New Orleans, Louisiana

Past Events
Sep 9 to Sep 13, 2022
ESMO 2022

Paris, France

Jun 23 to Jun 25, 2022

Toronto, Canada

Jun 9 to Jun 12, 2022
European School of Hematology

Vienna , Austria

Jun 3 to Jun 7, 2022
ASCO 3-7 Jun Chicago

Chicago, USA

May 24 to May 25, 2022
Congress Advanced Therapies

Meet the team at Advanced Therapies in London 

Mar 30 to Apr 2, 2022
European Lung Cancer


Mar 14 to Mar 15, 2022

London, England

Mar 11 to Mar 13, 2022
European School of Hematology

Budapest, Hungary
How to Treat AML SH 

Sep 21, 2021
Blood Cancer Awareness Month

Due to the rarity of the disease, data are lacking on the relationships between AML and most risk factors, and strong connections have not been made through epidemiological studies.

Sep 13, 2021
Blood Cancer Awareness Month

Secondary Acute Myeloid Leukaemia occurs more frequently in the elderly AML population than in younger patients and is typically more difficult to treat as it is less responsive to standard chemotherapies. 

Sep 7, 2021
Blood Cancer Awareness Month

The cause of AML is unknown; however, several risk factors have been associated with increased chance of developing AML, including, age, male sex, a history of smoking, and exposure to high doses of radiation and cytotoxic chemicals. 

Sep 2, 2021
Blood Cancer Awareness Month

Pleco’s team is working strenuously on the development of the PlecoidTM agents to increase the survival rate of patients with AML which is a disease carrying a poor prognosis.

Aug 1, 2021
World Lung Cancer

World Lung Cancer Day is taking place on the 1st of August 2021, PlecoTherapeutics is taking the opportunity to raise awareness to support patients and their families, especially those affected by Small Cell Lung Cancer (SCLC). 

Jun 16, 2021
Drug Repurposing for Rare Diseases 2021

Ivo Timmermans, Pleco’s CEO will be speaking at the Digital Conference Findacure’s annual Drug Repurposing Conference for RareDiseases on the 16th of June 2021. 

Jun 8, 2021
Ruffena Capital

Pleco Therapeutics’ CEO, Ivo Timmermans will present at the Investment Webinar organized by Ruffena Capital on the Tuesday 8th of June 2021 at 2pm.

Apr 21, 2021
KnowAML – KnowPlecoids World Awareness Day

Pleco Therapeutics aims to extend and enhance the lives of patients through its novel Plecoid therapies that increase the effectiveness of current cancer treatments.

Apr 15, 2021
Global Investor Forum 2021

Pleco is a proud finalist of Global Investor Forum 2021! Do you want to see us in the finale on 15 April during Innovation for Health?

Feb 1, 2021
Pleco team present at LSX World Congress

We are pleased to inform you that our board members Ivo Timmermans, Rudi Jansen and Gerben de Rijk will attend the 7th Annual LSX World Congress. This meeting will be delivered virtually, from 1 to 12 February

Feb 4, 2020
Events LSX World Congress in London

We are excited to share that our board members Ivo Timmermans and Rudi Jansen will attend the LSX World Congress in London. Our CEO Ivo Timmermans will give a presentation at the Biotech Showcase event

Nov 5 to Nov 7, 2019
CPHI Worldwide in Frankfurt

Our Chief Business Officer Rudi Jansen will be attending the Convention on Pharmaceutical Ingredients (CPHI Worldwide) in Frankfurt, Germany.